Stay updated with breaking news from Drug maker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Reddy s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore. ....
Together even as there have been some strains among some groups who have previously supported him. so the president coming back to washington tackling a huge plate of issues as he is heading closer to that 2024 election in november. arlette saenz, cnn, washington. police and the fbi are investigating a deadly car crash in new york that killed at least two people and injured five others. it happened early monday outside a concert venue. the collision was so powerful it launched both vehicles through pedestrian crossings. it took firefighters nearly an hour to put out the flames. bomb squad and arson task force were also called to the scene after at least a dozen gas canisters were found near one of the vehicles. more americans with diabetes will get a break on their insulin costs in 2024 with another leading drug maker now capping costs to help lower the price. meg terrell has those details. ....
reporter: the first of the year marks a major change in the way people who depend on insulin will pay for it. now sanofi is the third major manufacturer to offer a $35 per month price cap, at least on what people are paying out of pocket for their medications. this may be kind of complicated for people to access, they may have to go to the drug maker s websites and download a coupon, but at least it will available across the board from the three major manufacturers. more than 8 million people in the united states depend on insulin to live and according to the american diabetes association, a quarter of those people have at one point needed to ration their medicine in order to pay for it. and that can have really severe health consequences. another thing going into effect starting january 1 is decreases in the list prices of insulin of more than 70%. and the list price is the actual price of the medicine before insurance kicks in or any rebates or discounts are paid back into the syst ....
NEW DELHI: Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,6. ....